Analysts' optimism dwindles as they predict a revenue drop while EPS remains steady. The narrow estimate spread suggests easy valuation or strong views on future prospects. The consensus price target remains steady, indicating no major change in business prospects. However, Ingredion's revenues are expected to underperform the wider industry.